- Home
- GILD vs NKE Comparison
GILD vs NKE Comparison
Compare GILD & NKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- NKE
- Stock Information
- Founded
- GILD 1987
- NKE 1964
- Country
- GILD United States
- NKE United States
- Employees
- GILD N/A
- NKE N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- NKE Shoe Manufacturing
- Sector
- GILD Health Care
- NKE Consumer Discretionary
- Exchange
- GILD Nasdaq
- NKE Nasdaq
- Market Cap
- GILD 129.9B
- NKE 114.4B
- IPO Year
- GILD 1992
- NKE 1980
- Fundamental
- Price
- GILD $98.16
- NKE $58.88
- Analyst Decision
- GILD Buy
- NKE Buy
- Analyst Count
- GILD 26
- NKE 31
- Target Price
- GILD $108.00
- NKE $83.50
- AVG Volume (30 Days)
- GILD 8.7M
- NKE 18.7M
- Earning Date
- GILD 04-24-2025
- NKE 06-26-2025
- Dividend Yield
- GILD 3.22%
- NKE 2.72%
- EPS Growth
- GILD 1118.07
- NKE N/A
- EPS
- GILD 4.73
- NKE 3.01
- Revenue
- GILD $28,735,000,000.00
- NKE $47,818,000,000.00
- Revenue This Year
- GILD $1.88
- NKE N/A
- Revenue Next Year
- GILD $3.95
- NKE N/A
- P/E Ratio
- GILD $20.75
- NKE $19.54
- Revenue Growth
- GILD 4.68
- NKE N/A
- 52 Week Low
- GILD $62.07
- NKE $52.28
- 52 Week High
- GILD $119.96
- NKE $98.04
- Technical
- Relative Strength Index (RSI)
- GILD 36.39
- NKE 49.09
- Support Level
- GILD $93.37
- NKE $56.79
- Resistance Level
- GILD $107.17
- NKE $58.70
- Average True Range (ATR)
- GILD 3.64
- NKE 1.55
- MACD
- GILD -0.64
- NKE 0.79
- Stochastic Oscillator
- GILD 33.76
- NKE 78.14
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About NKE Nike Inc.
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.